MedAvail Holdings Inc. (MDVL) Social Stream
MEDAVAIL HOLDINGS INC (MDVL) Price Targets From Analysts
Use the tables below to see what analysts covering MEDAVAIL HOLDINGS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued April 6, 2022
The Trend in the Analyst Price Target
Over the past 168 days, MDVL's average price target has gone down $0.
Over the past 42 weeks, MDVL's average upside potential has been 367.78%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MDVL Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 35 weeks, MDVL's average broker recommendation rating improved by 0.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, MEDAVAIL HOLDINGS INC's number of analysts covering the stock is greater than practically none of them.
- In the context of all US stocks, MEDAVAIL HOLDINGS INC's upside potential (average analyst target price relative to current price) is higher than 675.31% of them.
- MDVL has a lower variance in analysts' estimates than 1.75% of Healthcare stocks.
- MDVL has a higher average analyst price target than 49.14% of Healthcare stocks.
Stocks similar to MEDAVAIL HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are SLS, ATNM, and CPRX.
View All Top Stocks by Price Target
Is MDVL a Buy, Hold or Sell? See the POWR Ratings now!